Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
Public Health
|
June 30, 2021
Dramatic decline in new HIV diagnoses in persons born in France in a large nationwide HIV cohort
A Le Guillou, A Cabie, C Delpierre, et al.
International Journal of STD & AIDS
|
December 22, 2012
Mean cost of a first combination antiretroviral therapy in HIV-infected patients in France, and determinants of expensive drugs prescription
V Colombie, S Pugliese-Wehrlen, S Deuffic-Burban, et al.
Oncology Reports
|
June 19, 2001
Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: a phase II study
S Brugnatelli, A Riccardi, M Danova, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 16, 2006
Nipple sparing mastectomy with immediate breast reconstruction: a short term analysis of our experience
A Psaila, M Pozzi, L Barone Adesi, et al.
Digestive Diseases and Sciences
|
April 25, 2001
Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: epidemiological study in an unselected population
F X Caroli-Bosc, P Le Gall, P Pugliese, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 13, 2006
Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis
D Fagnani, R Franchi, C Porta, et al.
International Journal of Oncology
|
March 16, 2000
Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer
A Riccardi, C Tinelli, S Brugnatelli, et al.
Anti-Cancer Drugs
|
September 23, 2000
Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patients
C Garufi, S Brienza, P Pugliese, et al.
British Journal of Cancer
|
July 20, 2001
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)
A Riccardi, P Pugliese, M Danova, et al.
Nephron. Clinical Practice
|
October 6, 2012
Increased time exposure to tenofovir is associated with a greater decrease in estimated glomerular filtration rate in HIV patients with kidney function of less than 60 ml/min/1.73 m2
C Fafin, P Pugliese, J Durant, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
Public Health
|
June 30, 2021
Dramatic decline in new HIV diagnoses in persons born in France in a large nationwide HIV cohort
A Le Guillou, A Cabie, C Delpierre, et al.
International Journal of STD & AIDS
|
December 22, 2012
Mean cost of a first combination antiretroviral therapy in HIV-infected patients in France, and determinants of expensive drugs prescription
V Colombie, S Pugliese-Wehrlen, S Deuffic-Burban, et al.
Oncology Reports
|
June 19, 2001
Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: a phase II study
S Brugnatelli, A Riccardi, M Danova, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 16, 2006
Nipple sparing mastectomy with immediate breast reconstruction: a short term analysis of our experience
A Psaila, M Pozzi, L Barone Adesi, et al.
Digestive Diseases and Sciences
|
April 25, 2001
Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: epidemiological study in an unselected population
F X Caroli-Bosc, P Le Gall, P Pugliese, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 13, 2006
Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis
D Fagnani, R Franchi, C Porta, et al.
International Journal of Oncology
|
March 16, 2000
Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer
A Riccardi, C Tinelli, S Brugnatelli, et al.
Anti-Cancer Drugs
|
September 23, 2000
Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patients
C Garufi, S Brienza, P Pugliese, et al.
British Journal of Cancer
|
July 20, 2001
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)
A Riccardi, P Pugliese, M Danova, et al.
Nephron. Clinical Practice
|
October 6, 2012
Increased time exposure to tenofovir is associated with a greater decrease in estimated glomerular filtration rate in HIV patients with kidney function of less than 60 ml/min/1.73 m2
C Fafin, P Pugliese, J Durant, et al.
Page
of 9